Q8C0D0
Gene name |
Trub1 |
Protein name |
Pseudouridylate synthase TRUB1 |
Names |
TruB pseudouridine synthase homolog 1, tRNA pseudouridine 55 synthase TRUB1, Psi55 synthase TRUB1 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:72133 |
EC number |
5.4.99.25: Transferring other groups |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8C0D0
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8C0D0-F1 | Predicted | AlphaFoldDB |
23 variants for Q8C0D0
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3409881808 | 7 | E>DVCVE* | No | EVA | |
| rs3389527820 | 13 | I>F | No | EVA | |
| rs3389550132 | 17 | A>T | No | EVA | |
| rs3409434392 | 49 | L>R | No | EVA | |
| rs249253439 | 56 | L>M | No | EVA | |
| rs3389505531 | 60 | F>I | No | EVA | |
| rs1133334873 | 81 | L>V | No | EVA | |
| rs1133705722 | 83 | A>V | No | EVA | |
| rs247760479 | 89 | S>F | No | EVA | |
| rs3389541444 | 110 | S>N | No | EVA | |
| rs3389552645 | 133 | G>R | No | EVA | |
| rs3409881838 | 137 | Y>F | No | EVA | |
| rs219539208 | 139 | T>A | No | EVA | |
| rs3389559740 | 193 | K>N | No | EVA | |
| rs1133536233 | 212 | P>L | No | EVA | |
| rs3389545014 | 216 | V>A | No | EVA | |
| rs3389541509 | 240 | G>D | No | EVA | |
| rs3389527807 | 248 | S>N | No | EVA | |
| rs36973114 | 289 | E>K | No | EVA | |
| rs3389545003 | 301 | E>D | No | EVA | |
| rs3389542326 | 306 | K>R | No | EVA | |
| rs3389541478 | 325 | L>F | No | EVA | |
| rs248991674 | 327 | D>E | No | EVA |
No associated diseases with Q8C0D0
3 regional properties for Q8C0D0
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Peptidyl-prolyl cis-trans isomerase, PpiC-type | 173 - 271 | IPR000297-1 |
| domain | Peptidyl-prolyl cis-trans isomerase, PpiC-type | 280 - 380 | IPR000297-2 |
| domain | SurA N-terminal | 27 - 144 | IPR015391 |
Functions
| Description | ||
|---|---|---|
| EC Number | 5.4.99.25 | Transferring other groups |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| mitochondrion | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| pre-miRNA binding | Binding to a precursor microRNA (pre-miRNA) transcript, a stem-loop-containing precursor of microRNA. |
| pseudouridine synthase activity | Catalysis of the reaction: RNA uridine = RNA pseudouridine. Conversion of uridine in an RNA molecule to pseudouridine by rotation of the C1'-N-1 glycosidic bond of uridine in RNA to a C1'-C5. |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| mRNA processing | Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide. |
| mRNA pseudouridine synthesis | The intramolecular conversion of uridine to pseudouridine in an mRNA molecule. |
| positive regulation of pre-miRNA processing | Any process that activates or increases the frequency, rate or extent of pre-microRNA processing. |
| tRNA modification | The covalent alteration of one or more nucleotides within a tRNA molecule to produce a tRNA molecule with a sequence that differs from that coded genetically. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAAAEAEVVS | PLIVDTAPDT | SGTAEASVAA | SVAEAARTES | QAPASKAALA | AKLMSLSGVF |
| 70 | 80 | 90 | 100 | 110 | 120 |
| AVHKPKGPTS | AELLNRLKEK | LLAEAGMPSP | EWNKRQKQTL | KVGHGGTLDS | AAQGVLVVGI |
| 130 | 140 | 150 | 160 | 170 | 180 |
| GRGTKMLTSM | LSGSKRYITI | GELGKATDTL | DSTGKVTEEK | PYDKITREDI | EGILQKFTGN |
| 190 | 200 | 210 | 220 | 230 | 240 |
| IMQVPPLYSA | LKKDGQRLST | LMKKGKVVEA | RPARPVTVHS | ISLLKFQPPF | FTLDVECGGG |
| 250 | 260 | 270 | 280 | 290 | 300 |
| FYIRSLVSDI | GKELSSCASV | LELTRTKQGP | FTLAQHALPE | DRWTIDDIEQ | SLERCTSLLP |
| 310 | 320 | 330 | |||
| EELTFKKLKS | DNSSDQVISC | GYITLRDTKR | EDDAVKTL |